-
1.
公开(公告)号:EP2024376A1
公开(公告)日:2009-02-18
申请号:EP07795059.0
申请日:2007-05-21
发明人: DININNO, Frank , HAMMOND, Milton, L. , DYKSTRA, Kevin , KIM, Seongkon , TAN, Qiang , YOUNG, Katherine , HERMES, Jeffrey, Donald , RAEPPEL, Stephane , MANNION, Michael , ZHOU, Nancy, Z. , GAUDETTE, Frederic , VAISBURG, Arkadii , RAHIL, Jubrail , GEORGOPAPADAKOU, Nafsika
IPC分类号: C07F9/6539 , C07F9/655 , C07F9/6553 , C07F9/6558 , A61K31/662 , A61P31/04
CPC分类号: C07F9/655354 , C07F9/6539 , C07F9/65517 , C07F9/655345 , C07F9/65586
摘要: This invention provides novel β-lactamase inhibitors of the aryl-and heteroaryl-sulfonamidomethylphosphonate monoester class. The compounds inhibit three classes of β-lactamases and synergize the antibacterial effects of β-lactam antibiotics (e.g., imipenem and ceftazimdime) against those micro-organisms normally resistant to the β-lactam antibiotics as a result of the presence of the β-lactamases. Formula (I) or a pro-drug or pharmaceutically acceptable salt thereof, wherein: W represents: Formula (II).
摘要翻译: 本发明提供了芳基 - 和杂芳基 - 磺酰胺甲基膦酸酯单酯类的新型β-内酰胺酶抑制剂。 由于β-内酰胺酶的存在,这些化合物抑制三类β-内酰胺酶并且协同β-内酰胺类抗生素(例如亚胺培南和头孢他啶)对通常对β-内酰胺类抗生素耐药的微生物的抗菌作用 。 式(I)或其前药或药学上可接受的盐,其中:W表示:式(II)。
-
公开(公告)号:EP2049200A2
公开(公告)日:2009-04-22
申请号:EP07870696.7
申请日:2007-05-21
申请人: MethylGene Inc.
发明人: DININNO, Frank , HAMMOND, Milton L. , DYKSTRA, Kevin , KIM, Seongkon , TAN, Qiang , YOUNG, Katherine , HERMES, Jeffrey Donald , CHEN, Helen , RAEPPEL, Stephane , MANNION, Michael , GAUDETTE, Frederic , VAISBURG, Arkadii , RAHIL, Jubrail , GEORGOPAPADAKOU, Nafsika , ZHOU, Nancy Z.
IPC分类号: A61P31/04 , C07F9/6539 , C07F9/6541 , C07F9/6553 , C07F9/6558 , C07F9/6561 , A61K31/67 , A61K31/675
CPC分类号: C07F9/655354 , C07F9/65395 , C07F9/6541 , C07F9/6553 , C07F9/6558 , C07F9/6561
摘要: This invention provides novel β-lactamase inhibitors of the aryl-and heteroarylsulfonarnidomethylphosphonate monoester class having nitrogen-based cations or quarternary ammomium groups. The compounds inhibit three classes of β-lactamases and synergize the antibacterial effects of β-lactam antibiotics (e.g., imipenem and ceftazimdime) against those micro-organisms normally resistant to the β-lactam antibiotics as a result of the presence of the β-lactamases. Formula (I) or pharmaceutically acceptable salt thereof.
-
公开(公告)号:EP2049200B1
公开(公告)日:2015-04-29
申请号:EP07870696.7
申请日:2007-05-21
申请人: MethylGene Inc.
发明人: DININNO, Frank , HAMMOND, Milton L. , DYKSTRA, Kevin , KIM, Seongkon , TAN, Qiang , YOUNG, Katherine , HERMES, Jeffrey Donald , CHEN, Helen , RAEPPEL, Stephane , MANNION, Michael , GAUDETTE, Frederic , VAISBURG, Arkadii , RAHL, Jubrail , GEORGOPAPADAKOU, Nafsika , ZHOU, Nancy Z.
IPC分类号: A61P31/04 , C07F9/6539 , C07F9/6541 , C07F9/6553 , C07F9/6558 , C07F9/6561 , A61K31/67 , A61K31/675
CPC分类号: C07F9/655354 , C07F9/65395 , C07F9/6541 , C07F9/6553 , C07F9/6558 , C07F9/6561
-
公开(公告)号:EP0656900A1
公开(公告)日:1995-06-14
申请号:EP93920228.0
申请日:1993-08-19
申请人: MERCK & CO. INC.
CPC分类号: C07D231/12 , C07D233/56 , C07D249/08 , C07D477/14
摘要: Carbapenems of formula (I) are useful antibacterial agents.
摘要翻译: 式(I)的碳青霉烯类是有用的抗菌剂。
-
-
-